Cargando…
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Currently, surgical resection, liver transplantation, and local ablation are considered curative therapeutic practices for HCC. The diagnosis of HCC without pathologic confirmation is achieved by analyzing serum...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177612/ https://www.ncbi.nlm.nih.gov/pubmed/24252133 http://dx.doi.org/10.1186/2050-7771-1-10 |